
CareTrust REIT (CTRE) Stock Forecast & Price Target
CareTrust REIT (CTRE) Analyst Ratings
Bulls say
CareTrust REIT is positioned for growth as its year-end 2025 estimated NAV is projected to rise to $24.05 per share, reflecting a solid increase from the prior year's estimate of $21.62 per share. The management's nearly completed portfolio optimization plan, alongside a core portfolio that exhibits signs of recovery, contributes positively to the overall investment outlook. Additionally, the company's strategic acquisitions, such as the $817 million purchase of a UK-based Care REIT, are expected to enhance enterprise value and bolster the growth potential of its healthcare real estate investments.
Bears say
The analysis indicates a negative outlook for CareTrust REIT's stock primarily due to a declining growth forecast and anticipated reductions in cash collections and investment activity, projected to decline by approximately 5% and to around $500 million, respectively. Additionally, the potential impact of California's CA 525 bill on operators' profitability raises concerns over rent pressures, exacerbating risks associated with tenant viability and reimbursement rates amid persistent Medicaid cuts. The company's ongoing stock decline since 2022 further suggests underlying market apprehensions regarding CareTrust REIT’s operational sustainability and overall financial health.
This aggregate rating is based on analysts' research of CareTrust REIT and is not a guaranteed prediction by Public.com or investment advice.
CareTrust REIT (CTRE) Analyst Forecast & Price Prediction
Start investing in CareTrust REIT (CTRE)
Order type
Buy in
Order amount
Est. shares
0 shares